Adjuvant chemotherapy of resistant high risk choriocarcinoma
نویسندگان
چکیده
Choriocarcinoma is a subtype of gestational trophoblastic disease. It very rare neoplasm, with incidence about 1 case in 40.000 pregnancies. Gestational form choriocarcinoma arises most commonly after abortion, while nongestational develops from pluripotent germ cells. Choricarcinoma highly malignant and chemosensitive type tumor. A 43-year-old patient diagnosed extra uterine pregnancy September 2017 was treated methotrexate no response had surgical removal right Fallopian tube. one half year pregnancy. Radiological imaging before treatment showed pulmonary inguinal lymph node metastases tumor invasion the anterior wall. Surgery performed due to heavy bleeding wall invasion. As high risk she received chemotherapy. She followed radiologically her serum ?-HCG monitored. Refractivity chemotherapy protocol during observed. Therapy achieved administration EMA-EP modification i.e. three consecutive negative follow-up values were obtained radiological findings disease free. One month signs level normal.
منابع مشابه
adjuVaNt chemOtherapy iN high-risk prOstate caNcer
In the RTOG 0521 study, patients with localized, nonmetastatic, high-risk prostate cancer were randomized to androgen suppression (AS) + radiotherapy (RT) vs AS+RT followed by chemotherapy (CT) with docetaxel and prednisone. High-risk prostate cancer categories were defined as: 1) Gleason (GL) 7–8, any T-stage, and prostate-specific antigen (PSA) ≥20, or 2) GL 8, ≥T2, any PSA, or 3) GL 9–10, an...
متن کامل"hysteroscopic ablation of choriocarcinoma in a patient resistant to chemotherapy "
gestational trophoblastic neoplasia ( gtn) is one of the most common gynecologic tumors in our country. despite development of effective chemotherapy: some cases remain resistant and if there is only focus of tumor, resection would be indicated.we present a young woman with stage 1 persistant gtn showing no response to chemotherapy. transvaginal sonograpy revealed trophoblastic tissue in the ut...
متن کاملHigh-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients.
In a study recently published in Annals of Oncology, Coombes et al. [1] reported the results of a prospective randomized trial comparing a short course of anthracycline-containing chemotherapy followed by high-dose chemotherapy with stemcell support (HDCT) versus a conventional-dose anthracyclinecontaining chemotherapy (CDCT) as adjuvant treatment in breast cancer patients with four or more pos...
متن کاملAdjuvant chemotherapy
The authors treated 10 advanced renal cell carcinoma with circadian venous continuous infusion of 5-Fluoro 2-Deoxyuridine (FUDR). The drug was delivered by Medtronic Synchromed implantable pump in 14-day cycles alternating with 14-day intervals of physiologic saline infusion. Of the patient observed for at least 8 months (range: 8-32, median: 22.1) 1 showed progression. Circadian continuous cen...
متن کاملEvaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
PURPOSE This study aimed at comparing the disease-free survival (DFS) in high-risk TNM stage II colon cancer patients who had been subjected to adjuvant chemotherapy and TNM low-risk stage II patients who did not receive chemotherapy. METHODS We retrospectively reviewed the medical records of stage II colon cancer patients between January 2006 and December 2011. High-risk patients were define...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archive of Oncology
سال: 2021
ISSN: ['0354-7310', '1450-9520']
DOI: https://doi.org/10.2298/aoo200408005d